Literature DB >> 32986347

Phylogeny and In Silico Structure Analysis of Major Capsid Protein (L1) Human Papillomavirus 45 from Indonesian Isolates.

Gita Widya Pradini1, Edhyana Sahiratmadja1, Sony Suhandono2, Sunarjati Sudigdoadi1, Muhammad Yusuf3, Ade Rizqi Ridwan Firdaus4, Herman Susanto5.   

Abstract

BACKGROUND: Human papillomavirus (HPV)-45 genotype circulates in high percentage in Bandung area - Indonesia, after HPV-16 and HPV-18. The aim of this study was to analyse variations of major capsid (L1) HPV-45 and its phylogeny. Furthermore in silico protein structure and epitope prediction was explored.
METHODS: L1 gene of HPV-45 was amplified, sequenced and aligned. Phylogenetic tree had been built and compared with a complete L1 HPV-45 sequence. Structure and epitope prediction of L1 protein were then developed in silico.
RESULTS: Of 5 L1 HPV-45 sequences collected, we have detected one variant of sub lineage A2 which was considered as a new variant, and two variants of B2. Superimposition of structure of these two variants with reference showed very similar structure. Furthermore, seven amino acid substitutions were found within these L1 variants of which two substitutions might change the polarity of corresponding amino acid I329T and S383G. The S383G occurred in surface loop (HI-Loop) of new L1 HPV-45 variant.
CONCLUSION: Similar structure of Indonesian variants indicates that amino acids variations do not affect the L1 structure. However, one substitution with altered amino acid polarity found within the area of surface loop suggests a potential impact in antibody recognition and neutralization.

Entities:  

Keywords:  HPV-45; Indonesia; L-1; Phylogeny; major capsid

Mesh:

Substances:

Year:  2020        PMID: 32986347      PMCID: PMC7779445          DOI: 10.31557/APJCP.2020.21.9.2517

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  28 in total

1.  A review of human carcinogens--Part B: biological agents.

Authors:  Véronique Bouvard; Robert Baan; Kurt Straif; Yann Grosse; Béatrice Secretan; Fatiha El Ghissassi; Lamia Benbrahim-Tallaa; Neela Guha; Crystal Freeman; Laurent Galichet; Vincent Cogliano
Journal:  Lancet Oncol       Date:  2009-04       Impact factor: 41.316

Review 2.  The papillomavirus major capsid protein L1.

Authors:  Christopher B Buck; Patricia M Day; Benes L Trus
Journal:  Virology       Date:  2013-06-22       Impact factor: 3.616

3.  A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasia.

Authors:  Mark Schiffman; Ana Cecilia Rodriguez; Zigui Chen; Sholom Wacholder; Rolando Herrero; Allan Hildesheim; Rob Desalle; Brian Befano; Kai Yu; Mahboobeh Safaeian; Mark E Sherman; Jorge Morales; Diego Guillen; Mario Alfaro; Martha Hutchinson; Diane Solomon; Philip E Castle; Robert D Burk
Journal:  Cancer Res       Date:  2010-03-30       Impact factor: 12.701

4.  Comparative protein modelling by satisfaction of spatial restraints.

Authors:  A Sali; T L Blundell
Journal:  J Mol Biol       Date:  1993-12-05       Impact factor: 5.469

5.  Naturally Occurring Major and Minor Capsid Protein Variants of Human Papillomavirus 45 (HPV45): Differential Recognition by Cross-Neutralizing Antibodies Generated by HPV Vaccines.

Authors:  Anna Godi; Alessandra Facchetti; Sara L Bissett; Clementina Cocuzza; Elizabeth Miller; Simon Beddows
Journal:  J Virol       Date:  2015-12-30       Impact factor: 5.103

Review 6.  Genome variation of human papillomavirus types: phylogenetic and medical implications.

Authors:  Hans-Ulrich Bernard; Itzel E Calleja-Macias; S Terence Dunn
Journal:  Int J Cancer       Date:  2006-03-01       Impact factor: 7.396

Review 7.  The Biological Impact of Genomic Diversity in Cervical Cancer Development.

Authors:  Cristina Mendes de Oliveira; José Eduardo Levi
Journal:  Acta Cytol       Date:  2016-10-22       Impact factor: 2.319

8.  Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16.

Authors:  X S Chen; R L Garcea; I Goldberg; G Casini; S C Harrison
Journal:  Mol Cell       Date:  2000-03       Impact factor: 17.970

9.  Human papillomavirus genotypes profile in cervical cancer patients at Dr. Hasan Sadikin General Hospital, Bandung, Indonesia.

Authors:  Maringan Diapari Lumban Tobing; Edhyana Sahiratmadja; Mufti Dinda; Bethy Suryawathy Hernowo; Herman Susanto
Journal:  Asian Pac J Cancer Prev       Date:  2014

10.  The DE and FG loops of the HPV major capsid protein contribute to the epitopes of vaccine-induced cross-neutralising antibodies.

Authors:  Sara L Bissett; Anna Godi; Simon Beddows
Journal:  Sci Rep       Date:  2016-12-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.